"The groundwork of all happiness is health." - Leigh Hunt

FDA approves updated non-mRNA COVID vaccine from Novavax

Oct. 4, 2023 – The Update Covid-19 vaccination The vaccine made by Novavax is now approved to be used within the U.S. and tens of millions of those doses are on their solution to pharmacies and other healthcare facilities.

Novavax CEO John Jacobs predicted it'll take per week or less for vaccinations to succeed in consumers.

“Today’s approval of Novavax means people now have a choice of a protein-based, non-MRNA option to protect themselves from COVID-19, now the fourth leading cause of death in the U.S.,” Jacobs said within the statement. “In the coming days, individuals across the U.S. will be able to go to major pharmacies, doctor’s offices, clinics and various government locations to receive an updated Novavax vaccine.”

The permit from the FDA comes as insurance and sales Challenges have hampered the rollout of updated vaccines from Pfizer and Moderna, that are already approved by the FDA. The CDC also approved the Novavax vaccine. Like the brand new Pfizer and Moderna vaccines, the Novavax shot has been tweaked to focus on evolved elements of the virus ahead of the colder months, when respiratory illnesses typically increase as people spend more time indoors.

The FDA said the Novavax shot is approved for anyone age 12 and older. Novavax uses a unique technology to trigger protection than Pfizer and Moderna's mRNA shots. Novavax works similarly to much older vaccines, including the childhood tetanus shot and the vaccines that prevent human papillomavirus (HPV) and hepatitis B virus, in accordance with a Summary from the Johns Hopkins Bloomberg School of Public Health.

In animal tests, the updated Novavax vaccine triggered immune responses against a few of the newer circulating variants. The Wall Street Journal reported.

Novavax has not been used as widely within the U.S. since it was approved much later within the pandemic in comparison with other COVID vaccines. As of May, nearly 90,000 doses of Novavax had been administered nationwide, compared with greater than 400 million doses from Pfizer and about 253 million doses from Moderna. CDC data showed.

A federal estimate suggests that at the least two million people within the U.S. have received the updated COVID-19 vaccine to this point, although the CDC is just not currently releasing regular updates on vaccination numbers because it once did.

Last month, the CDC really helpful that everybody 6 months and older get an updated COVID-19 vaccine this fall and winter.